These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1526652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T, Shi X, Guo D, Dong X, Xu X, Zhu D.
    Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040
    [Abstract] [Full Text] [Related]

  • 4. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T, Shi X, Guo D, Dong X, Xu X, Zhu D.
    Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
    [Abstract] [Full Text] [Related]

  • 5. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W.
    Nature; 1993 Jan 21; 361(6409):266-9. PubMed ID: 8380906
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity.
    Rathjen DA, Ferrante A, Aston R.
    Immunology; 1993 Oct 21; 80(2):293-9. PubMed ID: 8262557
    [Abstract] [Full Text] [Related]

  • 7. Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip region.
    Fonda I, Pernus M, Gaberc-Porekar V, Kenig M, Stalc A, Meager A, Menart V.
    Eur Cytokine Netw; 2005 Oct 21; 16(1):17-26. PubMed ID: 15809202
    [Abstract] [Full Text] [Related]

  • 8. Interactions between novel tumor necrosis factor-alpha mutants and receptors on tumor and normal cells.
    Nakamura S, Masegi T, Fukuoka M, Kitai K, Kato A, Ichikawa Y, Watanabe N, Niitsu Y.
    Agric Biol Chem; 1991 Jan 21; 55(1):53-7. PubMed ID: 1369315
    [Abstract] [Full Text] [Related]

  • 9. [Correlation of cytotoxic activity of mutant forms of tumor necrosis factor alpha with changes in the level of free sphingosine in murine liver].
    Solov'ev AS, Korobko VG, Shingarova LN, Vasil'eva SV, Makhova EV, Alesenko AV.
    Biokhimiia; 1995 Aug 21; 60(8):1283-91. PubMed ID: 7578580
    [Abstract] [Full Text] [Related]

  • 10. Muramyl peptides augment cytotoxic effect of tumor necrosis factor-alpha in combination with cytotoxic drugs on tumor cells.
    Petrova EE, Valyakina TI, Simonova MA, Komaleva RL, Khaidukov SV, Makarov EA, Blokhin DY, Ivanov PK, Andronova TM, Nesmeyanov VA.
    Int Immunopharmacol; 2006 Sep 21; 6(9):1377-86. PubMed ID: 16846831
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the site on a TNF-alpha molecule which affects type II TNF receptor binding in human cells.
    Ikegami H, Arai N, Moriyasu J, Taniguchi M, Tsusaki K, Honji N, Kohno K, Ando S, Kurimoto M.
    Lymphokine Cytokine Res; 1993 Jun 21; 12(3):173-80. PubMed ID: 7688581
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
    Vercammen D, Vandenabeele P, Declercq W, Van de Craen M, Grooten J, Fiers W.
    Cytokine; 1995 Jul 21; 7(5):463-70. PubMed ID: 7578985
    [Abstract] [Full Text] [Related]

  • 13. The role of iron in the cytotoxicity of tumor necrosis factor.
    Warren S, Torti SV, Torti FM.
    Lymphokine Cytokine Res; 1993 Apr 21; 12(2):75-80. PubMed ID: 8324080
    [Abstract] [Full Text] [Related]

  • 14. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y, Gatanaga M, Osuka Y, Kimura S, Burger RA, Granger GA, Gatanaga T.
    J Immunol; 1993 Jun 01; 150(11):5070-9. PubMed ID: 8098725
    [Abstract] [Full Text] [Related]

  • 15. Mutational analysis of human tumor necrosis factor-alpha.
    Shin HC, Cho KH.
    Biotechnol Lett; 2005 Jan 01; 27(2):107-12. PubMed ID: 15703873
    [Abstract] [Full Text] [Related]

  • 16. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo.
    Yan Z, Zhao N, Wang Z, Li B, Bao C, Shi J, Han W, Zhang Y.
    Cytotherapy; 2006 Jan 01; 8(4):415-23. PubMed ID: 16923618
    [Abstract] [Full Text] [Related]

  • 17. Chlorpromazine inhibits tumour necrosis factor synthesis and cytotoxicity in vitro.
    Zinetti M, Galli G, Demitri MT, Fantuzzi G, Minto M, Ghezzi P, Alzani R, Cozzi E, Fratelli M.
    Immunology; 1995 Nov 01; 86(3):416-21. PubMed ID: 8550079
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U, Benhar I, Webber KO, Pastan I, Brinkmann U.
    Clin Cancer Res; 1996 Sep 01; 2(9):1523-31. PubMed ID: 9816329
    [Abstract] [Full Text] [Related]

  • 19. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
    van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM.
    Exp Hematol; 1993 Mar 01; 21(3):461-8. PubMed ID: 8440344
    [Abstract] [Full Text] [Related]

  • 20. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA, Pace JL, Banerjee S, Phillips TA, Hunt JS.
    Placenta; 1999 Mar 01; 20(2-3):213-22. PubMed ID: 10195744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.